SCHEMBL16604273

SCHEMBL16604273

C=CCCCCCCCC(=O)OC(CCCCCCCC(C)=O)CS(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 5/20 0.38
USP2 O75604 3/20 0.38
CYP3A4 P08684 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
PRKCA P17252 2/20 0.37
ABCC4 O15439 1/20 0.36
RECQL P46063 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCD Q05655 1/20 0.36
MAPK1 P28482 1/20 0.35
FAAH O00519 2/20 0.35
MGLL Q99685 1/20 0.35
SLC6A5 Q9Y345 1/20 0.33
LPAR1 Q92633 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4550693 0.89 MAPT (0.51) ALDH1A1LMNAMAPTUSP2CYP3A4
SCHEMBL15216484 0.84 MAPK1 (0.53) ALDH1A1LMNAMAPTCYP3A4PRKCA
SCHEMBL20340354 0.79 LMNA (0.53) ALDH1A1LMNAMAPTUSP2CYP3A4
SCHEMBL11581266 0.78 MAPK1 (0.58) ALDH1A1LMNAMAPTCYP3A4PRKCA
SCHEMBL11581295 0.78 MAPK1 (0.58) ALDH1A1LMNAMAPTCYP3A4PRKCA
SCHEMBL11584970 0.78 MAPK1 (0.58) ALDH1A1LMNAMAPTCYP3A4PRKCA
SCHEMBL1483375 0.78 MAPK1 (0.58) ALDH1A1LMNAMAPTCYP3A4PRKCA
SCHEMBL4003560 0.77 MAPT (0.57) ALDH1A1LMNAMAPTHPGDPRKCA
SCHEMBL20500733 0.77 MAPT (0.57) ALDH1A1LMNAMAPTHPGDPRKCA
SCHEMBL11787560 0.77 MAPK1 (0.57) ALDH1A1LMNAMAPTCYP3A4PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150094383-A1 SYNERGISTIC SURFACTANT BLENDS STEPAN CO (US) 2015-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094383-A1 SYNERGISTIC SURFACTANT BLENDS HHAT, AADAT, SQLE ALDH1A1 2198/4885LMNA 2279/4885MAPT 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.